Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Perceptions of Patients, Caregivers, and Healthcare Providers of Idiopathic Inflammatory Myopathies: An International OMERACT Study.

Mecoli CA, Park JK, Alexanderson H, Regardt M, Needham M, de Groot I, Sarver C, Lundberg IE, Shea B, de Visser M, Song YW, Bingham CO 3rd, Christopher-Stine L.

J Rheumatol. 2018 Sep 15. pii: jrheum.180353. doi: 10.3899/jrheum.180353. [Epub ahead of print]

PMID:
30219767
2.

Muscle endurance deficits in myositis patients despite normal manual muscle testing scores.

Amici DR, Pinal-Fernandez I, Pagkatipunan R, Mears A, De Lorenzo R, Tiniakou E, Albayda J, Paik JJ, Lloyd TE, Christopher-Stine L, Mammen AL, Chung T.

Muscle Nerve. 2018 Jul 20. doi: 10.1002/mus.26307. [Epub ahead of print]

PMID:
30028529
3.

Advancing the Development of Patient-reported Outcomes for Adult Myositis at OMERACT 2016: An International Delphi Study.

Park JK, Mecoli CA, Alexanderson H, Regardt M, Christopher-Stine L, Casal-Domínguez M, de Groot I, Sarver C, Lundberg IE, Bingham CO 3rd, Song YW.

J Rheumatol. 2018 Jul;45(7):1071. doi: 10.3899/jrheum.161252.C2. No abstract available.

PMID:
29961681
4.

Pattern of muscle involvement in inclusion body myositis: a sonographic study.

Albayda J, Christopher-Stine L, Bingham Iii CO, Paik JJ, Tiniakou E, Billings S, Uy OM, Burlina P.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6):996-1002. Epub 2018 May 8.

5.

Muscular and extramuscular clinical features of patients with anti-PM/Scl autoantibodies.

De Lorenzo R, Pinal-Fernandez I, Huang W, Albayda J, Tiniakou E, Johnson C, Milisenda JC, Casal-Dominguez M, Corse AM, Danoff SK, Christopher-Stine L, Paik JJ, Mammen AL.

Neurology. 2018 Jun 5;90(23):e2068-e2076. doi: 10.1212/WNL.0000000000005638. Epub 2018 May 4.

PMID:
29728522
6.

The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis.

Schiffenbauer A, Faghihi-Kashani S, O'Hanlon TP, Flegel WA, Adams SD, Targoff IN, Oddis CV, Ytterberg SR, Aggarwal R, Christopher-Stine L, Shamim EA, Dellaripa PF, Danoff SK, Mammen AL, Miller FW.

Semin Arthritis Rheum. 2018 Feb 14. pii: S0049-0172(17)30630-3. doi: 10.1016/j.semarthrit.2018.02.003. [Epub ahead of print]

PMID:
29703532
7.

Update on outcome assessment in myositis.

Rider LG, Aggarwal R, Machado PM, Hogrel JY, Reed AM, Christopher-Stine L, Ruperto N.

Nat Rev Rheumatol. 2018 May;14(5):303-318. doi: 10.1038/nrrheum.2018.33. Epub 2018 Apr 12. Review.

PMID:
29651119
8.

Management of Interstitial Lung Disease in Patients With Myositis Specific Autoantibodies.

Mecoli CA, Christopher-Stine L.

Curr Rheumatol Rep. 2018 Apr 10;20(5):27. doi: 10.1007/s11926-018-0731-7. Review.

PMID:
29637383
9.

Triggers of inflammatory myopathy: insights into pathogenesis.

Adler BL, Christopher-Stine L.

Discov Med. 2018 Feb;25(136):75-83. Review.

10.

Calcinosis of the Mandible in Dermatomyositis.

Fava A, Christopher-Stine L.

Arthritis Rheumatol. 2018 Aug;70(8):1353. doi: 10.1002/art.40502. Epub 2018 Jun 14. No abstract available.

PMID:
29579373
11.

Mitochondrial DNA Deletions With Low-Level Heteroplasmy in Adult-Onset Myopathy.

Leung DG, Cohen JS, Michelle EH, Bai R, Mammen AL, Christopher-Stine L.

J Clin Neuromuscul Dis. 2018 Mar;19(3):117-123. doi: 10.1097/CND.0000000000000200.

PMID:
29465611
12.

Exploration of the MUC5B promoter variant and ILD risk in patients with autoimmune myositis.

Johnson C, Rosen P, Lloyd T, Horton M, Christopher-Stine L, Oddis CV, Mammen AL, Danoff SK.

Respir Med. 2017 Sep;130:52-54. doi: 10.1016/j.rmed.2017.07.010. Epub 2017 Jul 17.

PMID:
29206633
13.

Advancing the Development of Patient-reported Outcomes for Adult Myositis at OMERACT 2016: An International Delphi Study.

Park JK, Mecoli CA, Alexanderson H, Regardt M, Christopher-Stine L, Casal-Domínguez M, de Groot I, Sarver C, Lundberg IE, Bingham CO 3rd, Song YW.

J Rheumatol. 2017 Dec;44(12):1944. doi: 10.3899/jrheum.161252.C1. No abstract available.

PMID:
29196552
14.

Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research.

McCann LJ, Pilkington CA, Huber AM, Ravelli A, Appelbe D, Kirkham JJ, Williamson PR, Aggarwal A, Christopher-Stine L, Constantin T, Feldman BM, Lundberg I, Maillard S, Mathiesen P, Murphy R, Pachman LM, Reed AM, Rider LG, van Royen-Kerkof A, Russo R, Spinty S, Wedderburn LR, Beresford MW.

Ann Rheum Dis. 2018 Feb;77(2):241-250. doi: 10.1136/annrheumdis-2017-212141. Epub 2017 Oct 30.

15.

High-dose cyclophosphamide without stem cell rescue in immune-mediated necrotizing myopathies.

Mecoli CA, Lahouti AH, Brodsky RA, Mammen AL, Christopher-Stine L.

Neurol Neuroimmunol Neuroinflamm. 2017 Jul 7;4(5):e381. doi: 10.1212/NXI.0000000000000381. eCollection 2017 Sep. Erratum in: Neurol Neuroimmunol Neuroinflamm. 2018 Jun 05;5(4):e473.

16.

Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement.

Albayda J, Khan A, Casciola-Rosen L, Corse AM, Paik JJ, Christopher-Stine L.

Semin Arthritis Rheum. 2018 Feb;47(4):552-556. doi: 10.1016/j.semarthrit.2017.06.004. Epub 2017 Jun 13.

PMID:
28893408
17.

Immune-mediated necrotizing myopathy associated with statins: history and recent developments.

Tiniakou E, Christopher-Stine L.

Curr Opin Rheumatol. 2017 Nov;29(6):604-611. doi: 10.1097/BOR.0000000000000438. Review.

PMID:
28857949
18.

Advancing the Development of Patient-reported Outcomes for Adult Myositis at OMERACT 2016: An International Delphi Study.

Park JK, Mecoli CA, Alexanderson H, Regardt M, Christopher-Stine L, Casal-Domínguez M, de Groot I, Sarver C, Lundberg IE, Bingham CO 3rd, Song YW.

J Rheumatol. 2017 Nov;44(11):1683-1687. doi: 10.3899/jrheum.161252. Epub 2017 Aug 1. Erratum in: J Rheumatol. 2017 Dec;44(12 ):1944. J Rheumatol. 2018 Jul;45(7):1071.

19.

"Hiker's feet": a novel cutaneous finding in the inflammatory myopathies.

Cox JT, Gullotti DM, Mecoli CA, Lahouti AH, Albayda J, Paik J, Johnson C, Danoff SK, Mammen AL, Christopher-Stine L.

Clin Rheumatol. 2017 Jul;36(7):1683-1686. doi: 10.1007/s10067-017-3598-5. Epub 2017 Apr 7. Review.

20.

A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies.

Pinal-Fernandez I, Casal-Dominguez M, Huapaya JA, Albayda J, Paik JJ, Johnson C, Silhan L, Christopher-Stine L, Mammen AL, Danoff SK.

Rheumatology (Oxford). 2017 Jun 1;56(6):999-1007. doi: 10.1093/rheumatology/kex021.

21.

Calcium dysregulation, functional calpainopathy, and endoplasmic reticulum stress in sporadic inclusion body myositis.

Amici DR, Pinal-Fernandez I, Mázala DA, Lloyd TE, Corse AM, Christopher-Stine L, Mammen AL, Chin ER.

Acta Neuropathol Commun. 2017 Mar 22;5(1):24. doi: 10.1186/s40478-017-0427-7.

22.

Overlapping features of polymyositis and inclusion body myositis in HIV-infected patients.

Lloyd TE, Pinal-Fernandez I, Michelle EH, Christopher-Stine L, Pak K, Sacktor N, Mammen AL.

Neurology. 2017 Apr 11;88(15):1454-1460. doi: 10.1212/WNL.0000000000003821. Epub 2017 Mar 10.

23.

Statin-associated immune-mediated myopathy: biology and clinical implications.

Christopher-Stine L, Basharat P.

Curr Opin Lipidol. 2017 Apr;28(2):186-192. doi: 10.1097/MOL.0000000000000399. Review.

PMID:
28207435
24.

Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience.

Mecoli CA, Saylor D, Gelber AC, Christopher-Stine L.

Clin Exp Rheumatol. 2017 Jul-Aug;35(4):671-673. Epub 2017 Jan 27.

PMID:
28134084
25.

More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.

Tiniakou E, Pinal-Fernandez I, Lloyd TE, Albayda J, Paik J, Werner JL, Parks CA, Casciola-Rosen L, Christopher-Stine L, Mammen AL.

Rheumatology (Oxford). 2017 May 1;56(5):787-794. doi: 10.1093/rheumatology/kew470.

26.

Antinuclear Matrix Protein 2 Autoantibodies and Edema, Muscle Disease, and Malignancy Risk in Dermatomyositis Patients.

Albayda J, Pinal-Fernandez I, Huang W, Parks C, Paik J, Casciola-Rosen L, Danoff SK, Johnson C, Christopher-Stine L, Mammen AL.

Arthritis Care Res (Hoboken). 2017 Nov;69(11):1771-1776. doi: 10.1002/acr.23188.

27.

Erratum Corrige.

Tansley S, Shaddick G, Christopher-Stine L, Sharp C, Dourmishev L, Maurer B, Chinoy H, McHugh N.

Clin Exp Rheumatol. 2016 Nov-Dec;34(6):1127. Epub 2016 Nov 29. No abstract available.

28.

Mortality and Causes of Death in Patients with Sporadic Inclusion Body Myositis: Survey Study Based on the Clinical Experience of Specialists in Australia, Europe and the USA.

Price MA, Barghout V, Benveniste O, Christopher-Stine L, Corbett A, de Visser M, Hilton-Jones D, Kissel JT, Lloyd TE, Lundberg IE, Mastaglia F, Mozaffar T, Needham M, Schmidt J, Sivakumar K, DeMuro C, Tseng BS.

J Neuromuscul Dis. 2016 Mar 3;3(1):67-75.

29.

Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity.

Pinal-Fernandez I, Casal-Dominguez M, Carrino JA, Lahouti AH, Basharat P, Albayda J, Paik JJ, Ahlawat S, Danoff SK, Lloyd TE, Mammen AL, Christopher-Stine L.

Ann Rheum Dis. 2017 Apr;76(4):681-687. doi: 10.1136/annrheumdis-2016-210198. Epub 2016 Sep 20.

30.

A case of refractory dermatomyositis responsive to tofacitinib.

Paik JJ, Christopher-Stine L.

Semin Arthritis Rheum. 2017 Feb;46(4):e19. doi: 10.1016/j.semarthrit.2016.08.009. Epub 2016 Aug 17. No abstract available.

PMID:
27642158
31.

Statin-Induced Anti-HMGCR-Associated Myopathy.

Basharat P, Lahouti AH, Paik JJ, Albayda J, Pinal-Fernandez I, Bichile T, Lloyd TE, Danoff SK, Casciola-Rosen L, Mammen AL, Christopher-Stine L.

J Am Coll Cardiol. 2016 Jul 12;68(2):234-5. doi: 10.1016/j.jacc.2016.04.037. No abstract available.

32.

Developing standardised treatment for adults with myositis and different phenotypes: an international survey of current prescribing preferences.

Tansley S, Shaddick G, Christopher-Stine L, Sharp C, Dourmishev L, Maurer B, Chinoy H, McHugh N.

Clin Exp Rheumatol. 2016 Sep-Oct;34(5):880-884. Epub 2016 May 31. Erratum in: Clin Exp Rheumatol. 2016 Nov-Dec;34(6):1127.

PMID:
27243269
33.

Assessment of Mortality in Autoimmune Myositis With and Without Associated Interstitial Lung Disease.

Johnson C, Pinal-Fernandez I, Parikh R, Paik J, Albayda J, Mammen AL, Christopher-Stine L, Danoff S.

Lung. 2016 Oct;194(5):733-7. doi: 10.1007/s00408-016-9896-x. Epub 2016 May 11.

PMID:
27166633
34.

Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle.

Pinal-Fernandez I, Parks C, Werner JL, Albayda J, Paik J, Danoff SK, Casciola-Rosen L, Christopher-Stine L, Mammen AL.

Arthritis Care Res (Hoboken). 2017 Feb;69(2):263-270. doi: 10.1002/acr.22920. Epub 2016 Dec 31.

35.

An atypical case of dermatomyositis associated with chromophobe renal cell carcinoma.

George MD, Lahouti AH, Christopher-Stine L.

BMJ Case Rep. 2016 Jan 19;2016. pii: bcr2015212387. doi: 10.1136/bcr-2015-212387.

36.

Myositis-specific autoantibodies are specific for myositis compared to genetic muscle disease.

Mammen AL, Casciola-Rosen L, Christopher-Stine L, Lloyd TE, Wagner KR.

Neurol Neuroimmunol Neuroinflamm. 2015 Nov 19;2(6):e172. doi: 10.1212/NXI.0000000000000172. eCollection 2015 Dec.

37.

Patient Perspectives in OMERACT Provide an Anchor for Future Metric Development and Improved Approaches to Healthcare Delivery in Connective Tissue Disease Related Interstitial Lung Disease (CTD-ILD).

Mittoo S, Frankel S, LeSage D, Strand V, Shah AA, Christopher-Stine L, Danoff S, Hummers LK, Swigris JJ, Huscher D, Christensen AM, Cenac SL, Erbil JK, Ferguson S, Garcia-Valladares I, Grewal HK, Orbai AM, Smith KC, Tran M, Bingham CO 3rd, Castelino FV, Fischer A, Saketkoo LA.

Curr Respir Med Rev. 2015 Jun;11(2):175-183.

38.

Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.

Basharat P, Christopher-Stine L.

Curr Rheumatol Rep. 2015 Dec;17(12):72. doi: 10.1007/s11926-015-0548-6. Review.

PMID:
26515574
39.

Idiopathic Inflammatory Myopathy Treated With High-Dose Immunoablative Cyclophosphamide--A Long-term Follow-up Study.

Lahouti AH, Brodsky RA, Christopher-Stine L.

JAMA Neurol. 2015 Oct;72(10):1205-6. doi: 10.1001/jamaneurol.2015.1425. No abstract available.

PMID:
26457632
40.

The Prevalence of Individual Histopathologic Features Varies according to Autoantibody Status in Muscle Biopsies from Patients with Dermatomyositis.

Pinal-Fernandez I, Casciola-Rosen LA, Christopher-Stine L, Corse AM, Mammen AL.

J Rheumatol. 2015 Aug;42(8):1448-54.

PMID:
26443871
41.

PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjögren's syndrome.

Fiorentino DF, Presby M, Baer AN, Petri M, Rieger KE, Soloski M, Rosen A, Mammen AL, Christopher-Stine L, Casciola-Rosen L.

Ann Rheum Dis. 2016 Jun;75(6):1145-51. doi: 10.1136/annrheumdis-2015-207509. Epub 2015 Aug 7.

42.

Polymyositis and dermatomyositis: novel insights into the pathogenesis and potential therapeutic targets.

Lahouti AH, Christopher-Stine L.

Discov Med. 2015 Jun;19(107):463-70. Review.

43.

Patients' Experience of Myositis and Further Validation of a Myositis-specific Patient Reported Outcome Measure - Establishing Core Domains and Expanding Patient Input on Clinical Assessment in Myositis. Report from OMERACT 12.

Regardt M, Basharat P, Christopher-Stine L, Sarver C, Björn A, Lundberg IE, Wook Song Y, Bingham CO 3rd, Alexanderson H.

J Rheumatol. 2015 Dec;42(12):2492-5. doi: 10.3899/jrheum.141243. Epub 2015 May 1.

PMID:
25934817
44.

Cytosolic 5'-Nucleotidase 1A As a Target of Circulating Autoantibodies in Autoimmune Diseases.

Lloyd TE, Christopher-Stine L, Pinal-Fernandez I, Tiniakou E, Petri M, Baer A, Danoff SK, Pak K, Casciola-Rosen LA, Mammen AL.

Arthritis Care Res (Hoboken). 2016 Jan;68(1):66-71. doi: 10.1002/acr.22600.

45.

Genetic and immunologic susceptibility to statin-related myopathy.

Patel J, Superko HR, Martin SS, Blumenthal RS, Christopher-Stine L.

Atherosclerosis. 2015 May;240(1):260-71. doi: 10.1016/j.atherosclerosis.2015.03.025. Epub 2015 Mar 21. Review.

PMID:
25818852
46.

The composition of cellular infiltrates in anti-HMG-CoA reductase-associated myopathy.

Chung T, Christopher-Stine L, Paik JJ, Corse A, Mammen AL.

Muscle Nerve. 2015 Aug;52(2):189-95. doi: 10.1002/mus.24642. Epub 2015 May 14.

47.

Identifying statin-associated autoimmune necrotizing myopathy.

Albayda J, Christopher-Stine L.

Cleve Clin J Med. 2014 Dec;81(12):736-41. doi: 10.3949/ccjm.81a.13158. Review.

PMID:
25452351
48.

Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type.

Johnson C, Connors GR, Oaks J, Han S, Truong A, Richardson B, Lechtzin N, Mammen AL, Casciola-Rosen L, Christopher-Stine L, Danoff SK.

Respir Med. 2014 Oct;108(10):1542-8. doi: 10.1016/j.rmed.2014.09.003. Epub 2014 Sep 18.

49.

Inclusion body myositis: update.

Lahouti AH, Amato AA, Christopher-Stine L.

Curr Opin Rheumatol. 2014 Nov;26(6):690-6. doi: 10.1097/BOR.0000000000000116. Review.

PMID:
25215417
50.

Brief report: antisynthetase syndrome-associated myocarditis.

Sharma K, Orbai AM, Desai D, Cingolani OH, Halushka MK, Christopher-Stine L, Mammen AL, Wu KC, Zakaria S.

J Card Fail. 2014 Dec;20(12):939-45. doi: 10.1016/j.cardfail.2014.07.012. Epub 2014 Jul 29.

Supplemental Content

Loading ...
Support Center